Loading search results
SAFIR
10-week, Open, National, Multicenter Clinical Trial to Evaluate the Safety of Insulin Glargine in Type 2 Diabetes Mellitus Patients, on Intensified Conventional Therapy (ICT)
Sponsor study identifier
interventional
480
0 countries
N/A
Study Start
October 2003
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 2004
Actual (reported)Study Completion
March 2004
Actual (reported)Primary objective: Difference in frequency of subjects with conventionally detected hypoglycemia by the subject \[at least one measurement smaller/equal 60mg/dl documented in the 8-point profile in the case record form (CRF) or documentation of symptomatic hypoglycemia in the CRF through Visits 8/9\] compared to CGMS detected blood glucose values smaller/equal 60mg/dl during CGMS measurements (at least one measurement through Visits 8/9) after eight weeks of treatment with insulin glargine. Secondary objective: Secondary study objectives were to investigate the safety and efficacy of a treatment change to insulin glargine in ICT treated subjects in terms of:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 2004
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 2003
Date type not reportedThis date has not been verified as actual or estimated.
March 2004
Actual (reported)March 2004
Actual (reported)July 19, 2006
Actual (reported)July 20, 2006
Actual (reported)Frequency of subjects with conventionally detected hypoglycemia
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Zick R, Petersen B, Richter M, Haug C; SAFIR Study Group. Comparison of continuous blood glucose measurement with conventional documentation of hypoglycemia in patients with Type 2 diabetes on multiple daily insulin injection therapy. Diabetes Technol Ther. 2007 Dec;9(6):483-92. doi: 10.1089/dia.2007.0230.
Wolfgang Landgraf, Dr.
Sanofi
First Submitted
July 19, 2006
First Posted
July 20, 2006
Study Start
October 2003
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
March 2004
Actual (reported)Contact the study team to confirm eligibility.
Study Completion
March 2004
Actual (reported)Last Updated
August 31, 2010
Record last verified: 2010-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: